Globally, respiratory illnesses such as COPD, Asthma, Obstructive sleep apnea and other chronic respiratory disorders are becoming a common problem. According to WHO, every year about 65 million people suffer from Chronic Obstructive Pulmonary Disease (COPD), which is the third leading cause of death worldwide, about 334 million people are suffering from asthma of which 14%of the affected are children and more than 100 million people are suffering from a sleep breathing disorder. The factors which are responsible for the above respiratory conditions are smoking, infections, air pollution, genetic problems, and work hazards. So to prevent these respiratory conditions, companies are focusing on manufacturing respiratory care devices. Some of the devices used to treat respiratory diseases such as COPD, asthma, sleep apnea, cystic fibrosis, ARDS, Lung Cancer, Tuberculosis, pneumonia, and others are ventilators, nebulizers, inhalers, PAP devices, resuscitators, humidifiers, oxygen concentrators, pulse oximeters, capnographs, and gas analyzers.The respiratory care device’s global market is valued at $14,256.0 million in 2019 and is expected to grow at a CAGR of 7.4% to reach $23,510.9 million by 2026.
A major trend in the respiratory care devices market is emergence of homecare therapy. Homecare is the provision of equipment and services in the patient’s residences. This care can include residential, community care and hospices/palliative care. The main mission of the homecare services to clients with respiratory diseases is to improve survival, decrease morbidity, self-management and improves quality of life. COPD and cystic fibrosis sufferers are the most common patient groups who are receiving homecare services. Traditionally, patients with these respiratory conditions are using home oxygen therapy and airway management or tracheostomy tubes; however, there has been increasing in the usage of other respiratory care devices such as mechanical ventilation or continuous positive airway pressure therapy for the treatment of sleep apnea.
Due to the preference towards homecare settings, companies are coming up with specialized homecare services like resupply systems and rental services. One such service company is CHI health which is providing the devices at a lower cost, and the services allow patients to receive care and treatment in a comfortable and safe home environment. Similarly, sleep apnea therapy equipment requires regular maintenance and replacement to maintain comfortable, effective therapy. So Resmed is offering resupply program which provides timely PAP replacement to sleep apnea patients, this increases long-term adherence and improves satisfaction. Patients are enrolling more for automated resupply program.
In homecare services self-medicated devices such as nebulizers, inhalers and oxygen concentrators are used, but in some cases like patients under unhealthy conditions and for elderly patients need assistance. So, some hospitals are offering respiratory therapists and nurses who serve patients which includes oxygen therapy and airway management/tracheostomy care. Thus aiding to the growth of the home healthcare and home health agencies provide services to beneficiaries who are home bound and need skilled nursing or therapy.
Some of the major companies operating in the Respiratory care devices market area are Dragerwerk AG & Co. KGaA (Germany), Fisher and Paykel Healthcare (New Zealand), Inogen Inc., (U.S.), Medtronic PLC (Covidien) (Ireland), Philips N.V. (The Netherlands), ResmedInc (U.S.), Vyaire Medical, Inc (U.S.), Getinge Group (Maquet GmbH & Co. Kg) (Sweden), and GE Healthcare (U.S.).
For more information please visit our website: https://www.iq4i.com/reports-category/medicaldevices/r/117,
Write to us: email@example.com